Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Post by bbzzzzon Feb 28, 2019 3:14pm
135 Views
Post# 29424741

A possible Proxy battle ?? - Thank You Mr.Jokobsohn !!

A possible Proxy battle ?? - Thank You Mr.Jokobsohn !!Thanks for bring up issues that only a board member could substantiate and that relates to all shareholders waiting for magic to happen when really there may be no rabbit in the hat to pull out!

 What happened to the CBD craze that is sweeping North America in terms of GUD? Is it too late to take advantage of therapies that may be beneficial to all including shareholders? If conflict of interest is the case then I would support a proxy shareholder shake down of the board - Today!

 I respect Mr. Jokobsohn for his detailed , informative and hopefully provocative letter. I feel the frustration he must have been feeling in the tone of the letter and support him in whatever manner a shareholder could. 
 I hope that this open letter provokes a bell ringing wake up call to all shareholders and especially the board members that have no business being there ( see no pharma experience and friends of Goodman).
 
 I also respect the comment that a dividend is not paid by Gud but yet they have been receiving generous dividends from Medison and from the private equity deals in the pharma space. Yes, I would like a little love once a quarter at least ..minimum ! Respect for shareholders , please!!

 Thanks for being the guy to stand up and be counted Mr. Jokobsohn. WE should all take his lead and example to shake the tree as shareholders . Let's all do what we can to move this company forward. Start by a call to Investor Relations ( 514-678-8930 ).
 If you do not stand for something then you stand for nothing.

 tedz 
Bullboard Posts